NCT00492167 2022-03-07
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
Clinical Trials
3 trialsNCT00037011 2013-01-18
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00089258 2013-01-17
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Completed